WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'8401 Infant (under 12 months) mortality rate: 282
GDP / capita (US$): 9'6851 Child (under 5 years) mortality rate: 392

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 2'303  2'259  2'218  2'179  2'143  1'898  1'415  1'013 
Births 60  60  59  59  59  59  54  43 
Surviving infants 58  58  57  57  57  56  50  40 
Pop. less than 5 years 284  283  281  280  279  276  234  188 
Pop. less than 15 years 830  826  823  821  817  768  618  472 
Female 15-49 years 624  609  594  580  567  481  338  221 

Number of reported case

(Click for retrospective incidence data for Namibia)
Diphtheria
Japanese encephalitis
Measles 1'028  86  79  3'138  4'076  469 
Mumps
Pertussis 16  30 
Polio*
Rubella 40  42  140  22  27 
Rubella (CRS)
Tetanus (neonatal) 10  10 
Tetanus (total) 10  13  148  19 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Namibia)
Vaccine year result method % card seen                                                
BCG 2011  96  EPI   88  94  90  89  88  85  77  88 
DTP1 2011  96  EPI   88  94  89  88  87  87  90 
DTP3 2011  94  EPI   88  89  84  82  83  83  79  59 
HepB_BD         
HepB3 2011  94  EPI   88  89  84  82  83 
Hib3 2011  94  EPI   88  89  84  82  83 
JapEnc         
MCV 2011  89  EPI   88  82  76  74  75  76  69  57 
MCV2         
PCV1         
PCV3         
Pol3 2011  93  EPI   88  89  84  85  83  83  80  59 
Rota1         
Rota_last         
Rubella1         
TT2plus 2012  91  EPI   88  72  67  64  75  69  60  50 
PAB         
VAD1          82  75  74  64  93 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Namibia)
BCG 94  90  89  88  85  77 
DTP1 94  89  88  87  87  90 
DTP3 89  84  82  83  83  79 
HepB3 89  84  82  83 
HepB_BD
Hib3 89  84  82  83 
MCV 82  76  74  75  76  69 
MCV2
PAB 83  83  83  83  82  74 
PCV3
Pol3 89  84  85  83  83  80 
Rota_last

Number of districts in the country 35  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 60
From 80 to 89% 29
From 50 to 79% 9
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
2
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 5 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
Pneumo_conj Yes From October 2014
VitaminA 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  No  Yes  No 
What years does the MYP cover? number 2011 - 2015  2011 - 2015  2011 - 2015  2011 - 2015    2006-2010   
Nº of districts with microplans that include activities to raise immunization coverage number 34          34  34 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 35  34  34  34  34  34  34 
Nº districts with DTP3 coverage >=80% number 31  23  23  23  22  22 
% of districts with DTP3 coverage >=80% From 0 to 100% 89  68  68  68  65  65 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 20  12  15  18   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No    Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  45  100  100  100  100  100 

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.